MOSCA, MIRTA
 Distribuzione geografica
Continente #
NA - Nord America 111
EU - Europa 96
AS - Asia 75
AF - Africa 8
Totale 290
Nazione #
US - Stati Uniti d'America 111
SG - Singapore 38
IT - Italia 26
CN - Cina 21
SE - Svezia 17
CH - Svizzera 12
DE - Germania 11
IE - Irlanda 8
FI - Finlandia 6
IN - India 6
GB - Regno Unito 4
CI - Costa d'Avorio 3
ID - Indonesia 3
JO - Giordania 3
NL - Olanda 3
TG - Togo 3
BE - Belgio 2
BG - Bulgaria 2
FR - Francia 2
NG - Nigeria 2
AT - Austria 1
DK - Danimarca 1
HK - Hong Kong 1
PH - Filippine 1
PK - Pakistan 1
PL - Polonia 1
PS - Palestinian Territory 1
Totale 290
Città #
Singapore 38
Chandler 24
Santa Clara 16
Bern 12
Boardman 9
Ashburn 8
Dublin 8
Helsinki 6
Princeton 6
Hyderabad 5
Bologna 4
Fairfield 4
Fontanelice 4
New York 4
Abidjan 3
Amman 3
Frankfurt am Main 3
Jakarta 3
Lomé 3
Shanghai 3
Southend 3
Abeokuta 2
Berlin 2
Brussels 2
Falkenstein 2
Florence 2
Parma 2
Redmond 2
Rome 2
Sofia 2
Turin 2
Ann Arbor 1
Casalmaggiore 1
City of Westminster 1
Davao City 1
Dongguan 1
Foshan 1
Fremont 1
Gmina Zabierzów 1
Guangzhou 1
Halhul 1
Harbin 1
Hong Kong 1
Islamabad 1
Jinan 1
Milan 1
Mülheim 1
Nanjing 1
Nuremberg 1
Paris 1
Quanzhou 1
San Diego 1
San Francisco 1
Seattle 1
Shijiazhuang 1
Taicang 1
Vienna 1
Washington 1
Weifang 1
Zhengzhou 1
Totale 218
Nome #
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes 70
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases 66
Second-line treatment in advanced biliary tract cancer: Today and tomorrow 59
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumour Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes 38
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET) 20
Neutrophil-to-Lymphocyte Ratio (NLR) in NSCLC, Gastrointestinal, and Other Solid Tumors: Immunotherapy and Beyond 18
Non-small-cell lung cancer: how to manage RET-positive disease 14
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease 13
Clinical Outcome of Patients with Gastric, Duodenal, or Rectal Neuroendocrine Tumors after Incomplete Endoscopic Resection 11
Totale 309
Categoria #
all - tutte 1.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.659


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202227 0 0 0 0 0 0 0 1 7 4 6 9
2022/2023108 10 14 3 4 7 13 2 8 18 5 7 17
2023/202451 12 4 3 2 5 12 1 6 0 1 3 2
2024/2025123 18 18 28 13 28 13 5 0 0 0 0 0
Totale 309